Edition:
United States

Greenhill & Co Inc (GHL.N)

GHL.N on New York Stock Exchange

20.10USD
10:37am EST
Change (% chg)

$0.05 (+0.25%)
Prev Close
$20.05
Open
$20.05
Day's High
$20.15
Day's Low
$20.05
Volume
10,020
Avg. Vol
147,893
52-wk High
$31.35
52-wk Low
$13.80

Select another date:

Mon, Feb 12 2018

BRIEF-Greenhill Announces Terms For Modified Dutch Auction Tender Offer

* GREENHILL ANNOUNCES TERMS FOR MODIFIED DUTCH AUCTION TENDER OFFER

BRIEF-Greenhill & Co Reports Q4 Loss Per Share $0.85 Including Items

* GREENHILL & CO. REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS

BRIEF-Scott Bok Reports 5 Percent Stake In Greenhill & Co

* SCOTT BOK REPORTS 5 PERCENT STAKE IN GREENHILL & CO INC AS ON JANUARY 10 - SEC FILING Source text: (http://bit.ly/2CYcCTS) Further company coverage:

BRIEF-HSBC Has Appointed Anthony Parsons As Vice-Chairman, Global Banking From Greenhill

* HAS APPOINTED ANTHONY PARSONS AS VICE-CHAIRMAN, GLOBAL BANKING FROM GREENHILL Source text for Eikon: Further company coverage:

BRIEF-Greenhill & Co reports third quarter loss per share of $0.18

* Greenhill & Co Inc reports third quarter loss per share of $0.18

BRIEF-Greenhill & Co enters credit agreement

* Greenhill & Co Inc - ‍on October 12, co entered credit agreement - sec filing​

BRIEF-GREENHILL ANNOUNCES INCREASE IN PLANNED SHARE REPURCHASE TO $285 MLN

* GREENHILL ANNOUNCES REVISED TERMS FOR RECAPITALIZATION AND SHARE REPURCHASE

BRIEF-Greenhill announces plan for recapitalization and major share repurchase

* Greenhill announces plan for recapitalization and major share repurchase

BRIEF-Mabvax Therapeutics engages Greenhill & co. as advisor for exploring strategic alternatives

* Mabvax Therapeutics engages Greenhill & Co. as advisor for exploring strategic alternatives

Select another date: